Cas:39562-27-1 methyl 2-(o-nitrobenzylidene)-acetoacetate manufacturer & supplier

We serve Chemical Name:methyl 2-(o-nitrobenzylidene)-acetoacetate CAS:39562-27-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl 2-(o-nitrobenzylidene)-acetoacetate

Chemical Name:methyl 2-(o-nitrobenzylidene)-acetoacetate
CAS.NO:39562-27-1
Synonyms:2-NITROBENZYLIDENEMETHYLESTER;2-Nitrobenzylidenmethylester;2-Nitrobenzylidenacetessigsaeuremethylester;Methyl 2-(2′-nitrobenzylidene)acetoacetate;Nifedipine Impurity 4
Molecular Formula:C12H11NO5
Molecular Weight:249.21900
HS Code:2918300090

Physical and Chemical Properties:
Melting point:100-101 ºC (ethanol )
Boiling point:395.9ºC at 760mmHg
Density:1.296g/cm3
Index of Refraction:1.583
PSA:89.19000
Exact Mass:249.06400
LogP:2.26340

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-NITROBENZYLIDENEMETHYLESTER chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Nifedipine Impurity 4 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Nitrobenzylidenacetessigsaeuremethylester Use and application,Methyl 2-(2′-nitrobenzylidene)acetoacetate technical grade,usp/ep/jp grade.


Related News: It is delivered to hospitals and pharmacies until it reaches the patient. methyl 2-(o-nitrobenzylidene)-acetoacetate manufacturer Fears over the continuing spread of coronavirus have also fueled resentment and discrimination. Some have become outcasts in their own country, shunned by hotels, neighbors and — in some areas — placed under controversial quarantine measures. methyl 2-(o-nitrobenzylidene)-acetoacetate supplier In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. methyl 2-(o-nitrobenzylidene)-acetoacetate vendor Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations. methyl 2-(o-nitrobenzylidene)-acetoacetate factory From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said.